Journal Mobile Options
Table of Contents
Vol. 60, No. 3-4, 1992
Issue release date: 1992
Section title: Gene Mapping, Cloning, and Sequencing
Cytogenet Cell Genet 1992;60:212–213
(DOI:10.1159/000133340)

Localization of the human 75-kDal Fe-S protein of NADH-coenzyme Q reductase gene (NDUFS1) to 2q33→q34

Duncan A.M.V. · Chow W. · Robinson B.H.
aDepartment of Pathology, Queen’s University and Kingston General Hospital Kingston, Ontario, and bDepartments of Biochemistry and Paediatrics, University of Toronto and The Research Institute, Hospital for Sick Children, Toronto, Ontario (Canada)

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Gene Mapping, Cloning, and Sequencing

Accepted: 7/23/1991
Published online: 5/14/2008

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)

For additional information: http://www.karger.com/CGR

Abstract

The gene for the human 75-kDal Fe-S protein of the NADH-coenzyme Q reductase was localized to 2q33→q34 by in situ hybridization to human metaphase chromosomes banded, by BrdU-incorporation, to the 500–550 band level of resolution.


  

Author Contacts

Request reprints from Dr. B.H. Robinson, Department of Genetics, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G1X8 (Canada).

  

Article Information

Received: 23 July 1991
Published online: May 14, 2008
Number of Print Pages : 2

  

Publication Details

Cytogenetic and Genome Research

Vol. 60, No. 3-4, Year 1992 (Cover Date: 1992)

Journal Editor: Schmid M. (Würzburg)
ISSN: 1424–8581 (Print), eISSN: 1424–859X (Online)

For additional information: http://www.karger.com/CGR


Article / Publication Details

First-Page Preview
Abstract of Gene Mapping, Cloning, and Sequencing

Accepted: 7/23/1991
Published online: 5/14/2008

Number of Print Pages: 2
Number of Figures: 0
Number of Tables: 0

ISSN: 1424-8581 (Print)
eISSN: 1424-859X (Online)

For additional information: http://www.karger.com/CGR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.